Hashimoto-Gotoh T, Yasojima K, Tsujimura A
Department of Biochemistry and Molecular Genetics, Kyoto Prefectural University of Medicine, Japan.
Gene. 1995 Dec 29;167(1-2):333-4. doi: 10.1016/0378-1119(95)00705-9.
Plasmid vectors carrying lacZ' and kanamycin-resistance (KmR) genes were constructed for site-directed mutagenesis (SDM) using the oligodeoxyribonucleotide (oligo)-directed dual amber (ODA) method [Hashimoto-Gotoh et al., Gene 152 (1995) 271-276]. The plasmids, designated pKF16k, pKF17k, pKF18k and pKF19k, correspond to the previously reported chloramphenicol resistant (CmR) ODA plasmids, pKF16c, pKF17c, pKF18c and pKF19c, respectively, but contain dual amber (am) codons in KmR instead of the CmR gene. The SDM procedure using the KmR ODA plasmids is essentially the same as that with CmR ODA plasmids, which utilizes two oligo primers for in vitro DNA synthesis, one (selection primer) for dual am reversions and the other (mutagenic primer) for the target site. The KmR ODA plasmids yield 5-10-times more DNA per culture volume as compared to the CmR ODA plasmids, and one can prepare selection agar medium simply by spreading Km solution on dried agar plate at a final concentration of 50-100 micrograms/ml; due to the broad range of selecting antibiotic resistance.
携带lacZ'和卡那霉素抗性(KmR)基因的质粒载体通过寡脱氧核糖核苷酸(oligo)定向双琥珀突变(ODA)方法构建用于定点诱变(SDM)[桥本后藤等人,《基因》152(1995)271 - 276]。这些质粒分别命名为pKF16k、pKF17k、pKF18k和pKF19k,分别对应于先前报道的氯霉素抗性(CmR)ODA质粒pKF16c、pKF17c、pKF18c和pKF19c,但在KmR中含有双琥珀(am)密码子而非CmR基因。使用KmR ODA质粒的SDM程序与使用CmR ODA质粒的基本相同,该程序利用两个oligo引物进行体外DNA合成,一个(选择引物)用于双am回复,另一个(诱变引物)用于靶位点。与CmR ODA质粒相比,KmR ODA质粒每培养体积产生的DNA多5至10倍,并且只需将Km溶液以50 - 100微克/毫升的终浓度铺在干燥的琼脂平板上就能制备选择琼脂培养基;这是由于选择抗生素抗性的范围很广。